Pharmacyclics Presents Data Demonstrating Xcytrin`s Novel Mechanism of Action In Cancer
(PR Newswire)...Xcytrin increased cytotoxic response to bleomycin in clonogenic assays and other lab experiments, and increased tumor response to both agents in animal models.......Patient enrollment was recently completed in the company`s large international randomized Phase III study of Xcytrin for the treatment of brain metastases, i.e., advanced stage cancer that has spread from another part of the body to the brain.......Several other clinical studies are underway or being planned with Xcytrin in other tumor types, such as primary brain tumors, pancreatic cancer and non-small-cell lung cancer....- Mar 28 7:30 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010328/sfw011.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines